PMI
The 16th issue of the Scientific Update is co-edited by Pierpaolo Magnani, Global Head Regulatory Insights HnB. This issue focuses on the topic of real-world evidence by exploring in-depth examples of tobacco harm reduction success that can be found in Japan.
In this issue, Tomoki Iida, Director Regional scientific Engagement Asia, explains the impact that our leading heated tobacco product has on tobacco harm reduction in Japan as well as the local research and scientific communications that helped to make that impact possible. This issue also details the decline in cigarette sales in Japan, likely caused by the introduction of heated tobacco products, and the reduction in hospitalization trends for certain smoking-related diseases that also correlates with the introduction of heated tobacco products to Japan.
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.